Congratulations to Drs. Alfonso Martinez-Nunez, Adoflo Ramirez-Zamora, Michael Okun and Joshua Wong on the acceptance of “WHAT’S NEW IN 2024 FROM THE DEEP BRAIN STIMULATION THINK TANK XII: UPDATES IN NEUROTECHNOLOGY AND NEUROMODULATION, VOLUME V,” which will appear in Frontiers.
Neuromodulation has been fully integrated into clinical practice since the FDA approved deep brain stimulation (DBS) for the treatment of tremor almost three decades ago. Using the concepts learned from DBS, like network-based targeting, biophysical modeling of neuronal stimulation, and electrical stimulation settings, other forms of neuromodulation have been developed and are rapidly expanding and transforming current therapies. Since 2012, the DBS Think Tank has held annual meetings that gather the leading experts in the field of neuromodulation to discuss future directions and collaborations to exploit novel technologies with an overarching goal to advance the methods and outcomes of neuromodulation. This year’s XII Think Tank expanded its scope to discuss advances in DBS clinical applications for movement disorders, stroke, traumatic brain injury, sleep, epilepsy, and neuropsychiatric disorders.